Identification of Cancer Status for More Than 50 Cancer Types, as Well as Tissue of Origin Localizat (IMAGE)
Caption
Cell-free DNA is isolated from blood samples drawn from a patient without cancer (top) or with cancer (bottom), and subjected to a targeted methylation sequencing assay. Sequencing results identifying methylated (red) or unmethylated (blue) CpG regions are fed into a machine-learning classifier that can identify the presence or absence of cancer, as well as identify the tissue of origin (TOO).
Credit
Editorial Figure by Allen McCrodden, Associate Director, Creative Group of ProEd Communications
Usage Restrictions
Editorial Figure by Allen McCrodden, Associate Director, Creative Group of ProEd Communications
License
Licensed content